NanoViricides Inc. (NNVC)

[Puffer]

why has big pharma not already stepped in and provided funding?

A deal in the preclinical stage would have to be priced with a much higher risk premium and if the treatment should ultimately prove successful in humans would leave billions on the table. Docs Seymour and Diwan are not interested. As a shareholder, neither am I. As most big pharma deals are struck after Phase II clinical this is by no means a warning flag.

Also I still have doubts about efficacy in humans until the first tests are successful.

The fact that the mode of action works in the blood and requires no alteration of cell function, raises the odds of transferability to humans to a much higher level than the typical drug.

Nature has a way of adapting and it is an unknown how we and the virus targets will respond.

If a virus should adapt away from the cide receptor mimic, it would lose its ability to attach to the host receptors as well and thereby lose its ability to infect.